RACHEL VOUGHT: Open Payments
NPI 1629749684 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 83 payments from 14 companies in 2025. Trend: 2023 $2,281 · 2024 $2,342 · 2025 $1,582
Food & beverage: $1,503Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $592 |
| Janssen Biotech, Inc. | 10 | $228 |
| Madrigal Pharmaceuticals | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| GENZYME CORPORATION | 4 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Ardelyx, Inc. | 4 | $89 |
| Lilly USA, LLC | 3 | $67 |
| PFIZER INC. | 3 | $62 |
| Intercept Pharmaceuticals, Inc. | 2 | $47 |
Products named: RINVOQ, TREMFYA, LINZESS, REZDIFFRA, ENTYVIO, SKYRIZI, XIFAXAN, IBSRELA.
Industry payments across AL — which companies pay providers there.
